Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... testing and also to ascertain likely cause of weakly positive (grayzone) results. Results During the 17 month study ...

Alliance Global Partners analyst James Molloy lowered the firm’s price target on Barinthus Biotherapeutics (BRNS) to $6 from $7.50 and keeps a ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody ...

We similarly followed 16 children of hepatitis B surface antigen (HBsAg)-positive mothers. Results: Of low risk infants receiving a plasma-derived vaccine, 41% (42 of 102) of those whose primary ...

For patients at high risk of hepatitis B reactivation ... antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr.

For patients at high risk of hepatitis B reactivation ... antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr.

Blood tests for hepatitis A virus IgM, hepatitis B virus core IgM, hepatitis B virus surface antigen, and hepatitis ... test for treponemal antibodies was positive, and a rapid plasma reagin ...

Single-dose administration of E6F6 could profoundly suppress the levels of hepatitis B surface antigen (HBsAg) and HBV DNA for several weeks in HBV-transgenic mice. E6F6 regimen efficiently prevented ...

Those who are hepatitis B surface antigen-positive are eligible for enrollment if they have received hepatitis B virus (HBV) antiviral therapy and have undetectable HBV viral load prior to ...

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...